NCT00374478View on ClinicalTrials.gov

Effects of Transdermal Scopolamine on Occupational Performance

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2006

Conditions
Motion Sickness
Interventions
DRUG

Scopolamine

Trial Locations (1)

SE-391 82

Kalmar Maritime Academy, Kalmar

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Boston University

OTHER

NCT00374478 - Effects of Transdermal Scopolamine on Occupational Performance | Biotech Hunter | Biotech Hunter